Advertisement

Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px
Organisation › Details

Afyren SAS

AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN’s proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company’s sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN’s competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company’s first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). *

 

Period Start 2012-01-01 established
  Group Afyren (Group)
Products Industry industrial biotechnology
  Industry 2 GREEN BIOTECHNOLOGY
Persons Person Sordet, Nicolas (Afyren 202108 CEO + Co-Founder before Link Securities + BNP Paribas + Société Générale)
  Person 2 Pessiot, Jérémy (Afyren 202108 Managing Director + CTO + Co-Founder)
     
Region Region Clermont-Ferrand
  Country France
  Street 9-11 rue Gutenberg
  City 63100 Clemont-Ferrand
  Tel +33-4-7390-5116
    Address record changed: 2021-09-01
     
Basic data Employees B: 11 to 50 (2020-12-31)
  Annual sales 3,991,000 (revenues, consolidated (2020) 2020-12-31)
  Profit -2,133,000 (2020-12-31)
  Cash 9,508,000 (2020-12-31)
     
    * Document for »About Section«: Afyren SAS. (6/17/25). "Press Release: Afyren Begins New Phase of Industrial Strategy as First Plant Afyren Neoxy Achieves Continuous Production". Clermont-Ferrand / Lyon.
     
   
Record changed: 2026-05-02

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x200px

More documents for Afyren (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Portrait Bio:cap Investival for You 650x300px




» top